Penn Pharmaceutical Services, a leading UK provider of fully integrated pharmaceutical outsourcing services, has launched Penn Pharmaceutical Services US Inc. and has appointed Paul Wituschek as director of business development to drive the company's growth in North America. The new company will be based in Philadelphia.
"Following our recent MBO, and as part of our growth strategy, North America was identified as a key market," said Peter George, ceo of Penn Pharmaceuticals. "Many companies are already utilising Penn as a portal into Europe for their clinical trial supply and manufacture, import and release of pharmaceutical product."
Wituschek has more than 20 years" experience in executive level sales, marketing and management experience in private sector business. He has extensive background in the pharmaceutical, biotechnology, healthcare, insurance and publishing industries and has managed teams globally throughout North America, the UK and Europe. Most recently, he was global sales director for the Pharma Solutions business unit of Wolters Kluwer Health.
Penn employs more than 200 people and operates from a 323,000ft2 base in Tredegar, South Wales.